Back to 
Geode Capital Management, LLC
Geode Capital Management, LLC
CNSP2 quarters
Position history for Geode Capital Management, LLC's holdings in CNS Pharmaceuticals, Inc.
No. Geode Capital Management exited its CNSP (CNS Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 23,189 shares worth $55,653. Geode Capital Management first reported CNSP in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$55,653
Total Shares Change
-23,189
Quarter-by-Quarter History
Other major holders of CNSP: UBS Group AG, Vanguard Fiduciary Trust Co., Vanguard Capital Management LLC